We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award

By LabMedica International staff writers
Posted on 27 Jul 2023

Pattern Bioscience, Inc. More...

(Austin, TX, USA) has won the 2023 Disruptive Technology Award for its ground-breaking single-cell microbiology technology at the AACC Annual Scientific Meeting. The Disruptive Technology Award competition from ADLM honors innovative testing solutions and disruptive technologies that enhance patient care via diagnostic performance or improved access to high-quality testing. The finalists demonstrated their technologies live at the Disruptive Technology Award session during the event, with the winner being chosen by expert judges and announced at the session's conclusion.

Pattern has designed a novel culture-free test that rapidly identifies infection-causing pathogens and assesses their susceptibility to antibiotics. The test utilizes a fusion of single-cell analysis and AI to directly evaluate individual bacterial cells' responses to antibiotics, aiding healthcare teams in making informed decisions about antimicrobial therapy. Unlike PCR or sequence-based methods that evaluate genetic targets linked to resistance, Pattern’s technology directly measures the response of bacterial cells to antibiotics, thereby determining exactly which agents can be employed for therapy. This process is similar to standard-of-care culture methods, but significantly faster.

The single-cell microbiology technology developed by Pattern is capable of testing directly from complex clinical specimens, including non-sterile body sites where normal microbiota often coexists with pathogens. This unique ability to test directly from polymicrobial specimens stems from its single-cell isolation approach. The technology bypasses the traditional agar plate-based colony isolation process by encapsulating individual bacterial cells (or colony-forming units) in isolated picoliter-volume "culture droplets," creating an array of single-cell isolates. This critical process separates the antibiotic response of each bacteria type in the sample, enabling Pattern to deconvolve the antibiotic susceptibilities of multiple bacterial species. As such, Pattern’s technology is the first and only emerging technology capable of comprehensively diagnosing pneumonia directly from a clinical specimen, leading to the FDA granting the company’s Pneumonia ID/AST Panel a Breakthrough Device Designation.

Related Links:
Pattern Bioscience, Inc.


Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.